Experience

Bill Christiansen

    • GGV Capital Raises $2.5 Billion Across Four Funds 


    • Celularity to Go Public Through SPAC Merger 


    • Owl Ventures Closes $585 Million in New Funds to Support Edtech 


    • argenx – $557 Million Follow-On Offering 


    • Novo Holdings Leads $72 Million Series E for LanzaTech 


    • Advaxis – $30 Million Registered Direct Offering 


    • Gemphire Therapeutics – $30 Million IPO 


    • Syndax – $58 Million IPO 


    • Strongbridge Biopharma IPO 


    • NantKwest IPO - $238 Million IPO 


    • ProNAi Therapeutics - $158 Million IPO 


    • Chiasma Completes $117 Million IPO 


    • Celyad Completes IPO 


    • NantKwest – $238 Million IPO 


    • Catabasis Completes $69 Million IPO 


    • ProNAi – $158 Million IPO 


    • Aduro Completes $137 Million IPO 


    • Invitae Completes $117 Million Initial Public Offering  


    • Ascendis Pharma closes $124 million IPO 


    • Nexvet Biopharma Closes Initial Public Offering 


    • Xenon Pharmaceuticals Completes Initial Public Offering 


    • Atara – $63 Million IPO and Follow-On Offerings 


    • Demira Prices $125 Million IPO 


    • Otonomy $100 Million IPO 


    • Immune Design $63 Million Initial Public Offering 


    • Minerva Neurosciences $32.7 Million IPO 


    • Vital Therapies Initial Public Offering 


    • Cooley Advises Underwriters on Vital Therapies IPO 


    • Eleven Biotherapeutics IPO 


    • TetraLogic Initial Public Offering 


    • Five Prime Therapeutics IPO 


    • Onconova Therapeutics IPO 


    • Receptos, Inc. Initial Public Offering 


    • Jazz Pharmaceuticals in $314.4 million Offering 


    • Merus IPO – $61 Million